ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,689Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 2588

$1.08M Total Retail Price of All Prescriptions

Rank: 75 out of 2588

673 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 673 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 13,609 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 699 562 1 1
METOPROLOL TARTRATE 620 511 2 9
HYDROCODONE-ACETAMINOPHEN 572 405 S3 3 7
LISINOPRIL 549 435 4 3
AMLODIPINE BESYLATE 479 397 5 4
METFORMIN HCL 478 323 6 8
FUROSEMIDE 459 336 7 5
LEVOTHYROXINE SODIUM 421 362 8 2
METOPROLOL SUCCINATE 395 348 9 12
OMEPRAZOLE 384 288 10 6
RANITIDINE HCL 306 224 11 37
AZITHROMYCIN 303 200 12 45
DIOVAN 295 231 13 29
IBUPROFEN 283 116 14 62
ATORVASTATIN CALCIUM 270 249 15 11
PRAVASTATIN SODIUM 262 206 16 16
POTASSIUM CHLORIDE 256 168 17 15
METFORMIN HCL ER 246 190 18 67
CLOPIDOGREL 238 188 19 30
ENALAPRIL MALEATE 238 173 19 31
PROAIR HFA 218 114 21 50
NIFEDIPINE ER 214 196 22 59
LOSARTAN POTASSIUM 212 173 23 17
TAMSULOSIN HCL 199 177 24 23
JANUVIA 193 156 25 60
TRIAMTERENE-HCTZ 192 151 26 46
LOVASTATIN 191 136 27 34
CARVEDILOL 175 139 28 20
HYDRALAZINE HCL 174 139 29 53
ALENDRONATE SODIUM 164 116 30 21
PLAVIX 164 134 30 43
TRAMADOL HCL 164 104 30 19
GLIPIZIDE 164 136 30 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 161 125 34 35
WARFARIN SODIUM 156 144 35 10
ALLOPURINOL 151 117 36 33
PREDNISONE 151 113 36 42
FAMOTIDINE 148 135 38 36
DIGOXIN 143 117 39 38
CRESTOR 137 92 40 25
GABAPENTIN 136 77 41 18
PANTOPRAZOLE SODIUM 132 99 42 28
GLIMEPIRIDE 125 97 43 39
ACETAMINOPHEN-CODEINE 124 92 S3 44 80
ATENOLOL 124 77 44 14
FLUTICASONE PROPIONATE 117 59 46 40
ZOLPIDEM TARTRATE 116 90 47 24
GLYBURIDE 115 84 R 48 65
TRIAMCINOLONE ACETONIDE 114 74 49 106
DIOVAN HCT 110 82 50 72
CLONIDINE HCL 107 84 51 54
HYDROCHLOROTHIAZIDE 106 82 52 13
HYDROXYZINE HCL 102 54 R 53 194
LOSARTAN-HYDROCHLOROTHIAZIDE 98 88 54 66
GLYBURIDE-METFORMIN HCL 97 70 R 55 162
INSULIN SYRINGE 94 79 56 81
GLIPIZIDE ER 91 69 57 73
NIFEDICAL XL 82 75 58 179
VERAPAMIL ER 81 81 59 102
VENTOLIN HFA 81 47 59 101
ROPINIROLE HCL 81 69 59 113
CITALOPRAM HBR 79 55 62 27
KLOR-CON M20 77 65 63 52
ACTOS 77 58 63 105
CEPHALEXIN 77 49 63 138
NAPROXEN 74 42 66 95
PAROXETINE HCL 72 66 67 71
CYMBALTA 71 52 68 70
AMOXICILLIN 71 39 68 130
AMLODIPINE BESYLATE-BENAZEPRIL 70 43 70 76
LANTUS 65 52 71 47
NEXIUM 65 35 71 41
SPIRIVA 64 45 73 56
SPIRONOLACTONE-HCTZ 64 52 73 201
AVODART 62 62 75 164
FENOFIBRATE 60 30 76 64
LEVETIRACETAM 59 31 77 90
PEN NEEDLE 58 13 78 112
ISOSORBIDE MONONITRATE ER 58 58 78 49
CIPROFLOXACIN HCL 57 46 80 82
LOVAZA 57 0 80 119
NAMENDA 54 54 82 32
GEMFIBROZIL 53 30 83 123
TRAZODONE HCL 53 32 83 61
DONEPEZIL HCL 53 53 83 22
ADVAIR DISKUS 51 29 86 48
AMOX TR-POTASSIUM CLAVULANATE 51 26 86 131
NIASPAN 50 29 88 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.